It's no secret, we know that market barrows perform better than gilts. But should we look at this challenge as a cost of business or revenue opportunity? A recent KSU published paper has economically quantified the Gilt Gap at an estimated -$3.60/gilt for producers and -$5.00/gilt for integrators compared to barrows. Hear from two experts – Dr. Steve Pollmann, nutritionist and industry consultant, and Dr. Ben Bohrer, OSU Meat Scientist, discuss how IMPROVEST® (gonadotropin releasing factor analog-diphtheria toxoid conjugate) 0.2 mg/mL, now approved for temporarily suppressing estrus in gilts, can help the industry produce market gilts that perform more like barrows.

Attend this webinar and learn about IMPROVEST research1 outcomes in gilts, as a result of temporarily suppressing estrus:

1Nautrup, BP, et al., Res Vet Sci, 2020

IMPORTANT SAFETY INFORMATION: Pregnant women should not administer IMPROVEST. Women of childbearing age should exercise extreme caution when administering this product. Exercise special care to prevent accidental self-injection because of negative effects on reproductive physiology in both men and women. Do not use IMPROVEST in male pigs or gilts intended for breeding, or in barrows, cull boars or sows. See full Prescribing Information.